Edward Septimus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Edward Septimus has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Susan S. Huang
University of California Irvine School of Medicine
5 shared publications - Richard Platt
Department of Population Medicine, Harvard Pilgrim Healthcare Institute, Harvard Medical School, Boston, Massachusetts
4 shared publications - Julia Moody
HCA Healthcare, Nashville, Tennessee
3 shared publications - Adrian F. Hernandez
Duke University School of Medicine, Durham, North Carolina, USA
2 shared publications - Beverly B. Green
Kaiser Permanente Washington Health Research Institute, Seattle, Washington
2 shared publications Brandon Carver
HCA Healthcare, Nashville, Tennessee
2 shared publications
Latest Publications
- Open Access
- 27 November 2023
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 10 (Supplement)
2476. Universal detection of healthcare-related bacterial transmissions using de novo assembly with short-read whole genome sequencing
Whole genome sequencing (WGS) is the gold standard for molecular evidence of pathogen transmission. To date, most WGS investigations within healthcare settings have used low cost short-read technologies (e.g., Illumina), aligning reads to a high quality reference genome. However, this relies on either public repositories having closely-related high quality references, which is not guaranteed for arbitrary clinical isolates, or additional long-read sequencing. De novo assembly avoids reliance on references, but the utility of fragmented assemblies of short reads is not well-established in hospital outbreak investigations. 24 clusters of clinical isolates were identified by automated and routine methods at 17 U.S. hospitals and underwent paired-end WGS on Illumina platforms, followed by two parallel analyses. For a reference-free analysis, de novo assembly was performed with Shovill, assemblies were clustered with Mash, core-genome alignments were created with Harvest, and finally single nucleotide polymorphism (SNP) distances were visualized using the PathoSPOT phylogenomics toolkit to highlight likely transmission events. For a reference-guided analysis, references were selected for each isolate using StrainGST, and SNPs called by read alignment were used to define phylogenomic distances. Finally, conclusions from both analyses were compared. 92 bacterial isolates underwent WGS, of which 86 (93%) completed de novo assembly and passed quality control, comprising 10 isolates of Acinetobacter baumanii, 4 of Klebsiella oxytoca, 46 of Klebsiella pneumoniae, and 26 of Staphylococcus aureus. Reference-free analysis with PathoSPOT identified close relatedness consistent with transmission in 13 of 24 clusters (54%), while the reference-guided analysis identified the same in 12 clusters (50%). Overall, 21 clusters (88%) showed concordance between reference-free and reference-guided methods. Cohen’s kappa indicated substantial agreement (0.75; 95% CI, 0.49–1.0). De novo assembly of short reads is tenable for WGS investigation of hospital outbreaks, elides the need for reference genomes or long-read sequencing, and compares favorably with SNP calling via read alignment for detecting likely healthcare-related transmissions. Laura E. McLean, M.Ed., HCA Healthcare: Stocks/Bonds Susan S. Huang, MD MPH, Medline Industries, Inc: Conducted studies whereby participating nursing homes and hospital patients received cleaning & antiseptic products|Xttrium Laboratories: Conducted studies where participating nursing homes and hospital patients received antiseptic products Yonatan H. Grad, MD, PhD, Day Zero Diagnostics: Board Member|GSK: Advisor/Consultant
- 27 November 2023
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 10 (Supplement)
Open Access2476. Universal detection of healthcare-related bacterial transmissions using de novo assembly with short-read whole genome sequencing
Whole genome sequencing (WGS) is the gold standard for molecular evidence of pathogen transmission. To date, most WGS investigations within healthcare settings have used low cost short-read technologies (e.g., Illumina), aligning reads to a high quality reference genome. However, this relies on either public repositories having closely-related high quality references, which is not guaranteed for arbitrary clinical isolates, or additional long-read sequencing. De novo assembly avoids reliance on references, but the utility of fragmented assemblies of short reads is not well-established in hospital outbreak investigations. 24 clusters of clinical isolates were identified by automated and routine methods at 17 U.S. hospitals and underwent paired-end WGS on Illumina platforms, followed by two parallel analyses. For a reference-free analysis, de novo assembly was performed with Shovill, assemblies were clustered with Mash, core-genome alignments were created with Harvest, and finally single nucleotide polymorphism (SNP) distances were visualized using the PathoSPOT phylogenomics toolkit to highlight likely transmission events. For a reference-guided analysis, references were selected for each isolate using StrainGST, and SNPs called by read alignment were used to define phylogenomic distances. Finally, conclusions from both analyses were compared. 92 bacterial isolates underwent WGS, of which 86 (93%) completed de novo assembly and passed quality control, comprising 10 isolates of Acinetobacter baumanii, 4 of Klebsiella oxytoca, 46 of Klebsiella pneumoniae, and 26 of Staphylococcus aureus. Reference-free analysis with PathoSPOT identified close relatedness consistent with transmission in 13 of 24 clusters (54%), while the reference-guided analysis identified the same in 12 clusters (50%). Overall, 21 clusters (88%) showed concordance between reference-free and reference-guided methods. Cohen’s kappa indicated substantial agreement (0.75; 95% CI, 0.49–1.0). De novo assembly of short reads is tenable for WGS investigation of hospital outbreaks, elides the need for reference genomes or long-read sequencing, and compares favorably with SNP calling via read alignment for detecting likely healthcare-related transmissions. Laura E. McLean, M.Ed., HCA Healthcare: Stocks/Bonds Susan S. Huang, MD MPH, Medline Industries, Inc: Conducted studies whereby participating nursing homes and hospital patients received cleaning & antiseptic products|Xttrium Laboratories: Conducted studies where participating nursing homes and hospital patients received antiseptic products Yonatan H. Grad, MD, PhD, Day Zero Diagnostics: Board Member|GSK: Advisor/Consultant
- Open Access
- 1 June 2023
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 44 (12) , 2074-2077
Coronavirus disease 2019 (COVID-19) infection prevention practices that exceed Centers for Disease Control and Prevention (CDC) guidance: Balancing extra caution against impediments to care
In a survey of infection prevention programs, leaders reported frequent clinical and infection prevention practice modifications to avoid coronavirus disease 2019 (COVID-19) exposure that exceeded national guidance. Future pandemic responses should emphasize balanced approaches to precautions, prioritize educational campaigns to manage safety concerns, and generate an evidence-base that can guide appropriate infection prevention practices.
- 1 June 2023
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 44 (12) , 2074-2077
Open AccessCoronavirus disease 2019 (COVID-19) infection prevention practices that exceed Centers for Disease Control and Prevention (CDC) guidance: Balancing extra caution against impediments to care
In a survey of infection prevention programs, leaders reported frequent clinical and infection prevention practice modifications to avoid coronavirus disease 2019 (COVID-19) exposure that exceeded national guidance. Future pandemic responses should emphasize balanced approaches to precautions, prioritize educational campaigns to manage safety concerns, and generate an evidence-base that can guide appropriate infection prevention practices.
- 9 November 2022
- Published by H1 Connect
Faculty Opinions recommendation of Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines.
This article uses a Candian database to follow individuals exposed to the second dose of an mRNA vaccine. The primary objective was diagnosis of myocarditis and pericarditis. Although the risk was low, Moderna had a higher risk for both myocarditis and pericarditis. Myocarditis was not observed in persons over age 40, while pericarditis can be seen in an older age group. Young males are at a higher risk than females. This study confirms prior studies. In spite of a small risk from vaccination, the risk of myocarditis and pericarditis are higher with natural disease.
- 9 November 2022
- Published by H1 Connect
Faculty Opinions recommendation of Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines.
This article uses a Candian database to follow individuals exposed to the second dose of an mRNA vaccine. The primary objective was diagnosis of myocarditis and pericarditis. Although the risk was low, Moderna had a higher risk for both myocarditis and pericarditis. Myocarditis was not observed in persons over age 40, while pericarditis can be seen in an older age group. Young males are at a higher risk than females. This study confirms prior studies. In spite of a small risk from vaccination, the risk of myocarditis and pericarditis are higher with natural disease.
- 20 August 2022
- Published by H1 Connect
Faculty Opinions recommendation of Ultrashort course antibiotics for suspected pneumonia with preserved oxygenation.
The investigators reviewed all patients started on antibiotics for CAP with normal oxygen saturation on room air. They performed a propensity match for patients treated for 1-2 days versus 5-8 days. They discovered that 25% of patients admitted for CAP had normal oxygen saturation on room air. Outcomes (mortality, time to discharge, readmissions, C. difficile infections) were similar for patients treated for 1-2 days versus 5-8 days. They listed the following explanations: first, some patients admitted, in fact, did not have true pneumonia; second, some may have had viral pneumonia-recent studies have shown that in adults, viral pneumonia makes up 15-30% of cases of CAP; lastly, some may have early mild bacterial pneumonia. The take-home message in many cases of mild true bacterial CAP, a short course of antibiotics has been shown to be as effective as longer courses with fewer side effects. The other message to clinicians is that in patients with normal oxygen saturation on room air is to look for other causes for patients presenting with nonspecific symptoms.
- 20 August 2022
- Published by H1 Connect
Faculty Opinions recommendation of Ultrashort course antibiotics for suspected pneumonia with preserved oxygenation.
The investigators reviewed all patients started on antibiotics for CAP with normal oxygen saturation on room air. They performed a propensity match for patients treated for 1-2 days versus 5-8 days. They discovered that 25% of patients admitted for CAP had normal oxygen saturation on room air. Outcomes (mortality, time to discharge, readmissions, C. difficile infections) were similar for patients treated for 1-2 days versus 5-8 days. They listed the following explanations: first, some patients admitted, in fact, did not have true pneumonia; second, some may have had viral pneumonia-recent studies have shown that in adults, viral pneumonia makes up 15-30% of cases of CAP; lastly, some may have early mild bacterial pneumonia. The take-home message in many cases of mild true bacterial CAP, a short course of antibiotics has been shown to be as effective as longer courses with fewer side effects. The other message to clinicians is that in patients with normal oxygen saturation on room air is to look for other causes for patients presenting with nonspecific symptoms.
- 24 February 2020
- Published by H1 Connect
Faculty Opinions recommendation of Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia.
This is a retrospective, multicenter cohort study conducted of all hospitalizations in which patients receiving either anti-methicillin-resistant Staphylococcus aureus (MRSA) or standard therapy for community-onset pneumonia in the Veterans Health Administration health care system. This study suggests that empirical anti-MRSA therapy was not associated with reduced mortality for any group of patients hospitalized for pneumonia but was associated with increase harm including kidney injury, Clostridium difficile, and vancomycin-resistant Enterococci (VRE). Documented MRSA pneumonia was <5% but over one-third received either vancomycin or linezolid. This is another study that documents that unnecessary extend-spectrum antibiotics do not improve outcomes and may in fact be associated with increased harm. Unless a patient has a strong risk for MRSA, standard therapy for pneumonia is preferred.
- 24 February 2020
- Published by H1 Connect
Faculty Opinions recommendation of Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia.
This is a retrospective, multicenter cohort study conducted of all hospitalizations in which patients receiving either anti-methicillin-resistant Staphylococcus aureus (MRSA) or standard therapy for community-onset pneumonia in the Veterans Health Administration health care system. This study suggests that empirical anti-MRSA therapy was not associated with reduced mortality for any group of patients hospitalized for pneumonia but was associated with increase harm including kidney injury, Clostridium difficile, and vancomycin-resistant Enterococci (VRE). Documented MRSA pneumonia was <5% but over one-third received either vancomycin or linezolid. This is another study that documents that unnecessary extend-spectrum antibiotics do not improve outcomes and may in fact be associated with increased harm. Unless a patient has a strong risk for MRSA, standard therapy for pneumonia is preferred.
- 20 January 2020
- Published by H1 Connect
Faculty Opinions recommendation of Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial.
This is important work determining whether inhaled antibiotics add anything to routine intravenous (IV) antibiotics for the treatment of Gram-negative pneumonia in patients on ventilators. This is a well done randomized double-blinded trial on inhaled amikacin versus saline. The bottom line was that inhaled amikacin did not improve outcomes. The trial did not address pan-resistant Gram-negative pneumonia. Many facilities use inhaled aminoglycosides and colistin for Gram-negative pneumonias -- this study demonstrates that it does not improve results over an appropriate IV antibiotic.
- 20 January 2020
- Published by H1 Connect
Faculty Opinions recommendation of Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial.
This is important work determining whether inhaled antibiotics add anything to routine intravenous (IV) antibiotics for the treatment of Gram-negative pneumonia in patients on ventilators. This is a well done randomized double-blinded trial on inhaled amikacin versus saline. The bottom line was that inhaled amikacin did not improve outcomes. The trial did not address pan-resistant Gram-negative pneumonia. Many facilities use inhaled aminoglycosides and colistin for Gram-negative pneumonias -- this study demonstrates that it does not improve results over an appropriate IV antibiotic.
- 16 December 2019
- Published by H1 Connect
Faculty Opinions recommendation of Screening of Clostridioides difficile carriers in an urban academic medical center: Understanding implications of disease.
This is a prospective cohort single site study; the study included only 220 subjects, so it was small. Perirectal swabs were tested by PCR for C. difficile within 24 hours of admission, and patients were followed for progression to symptomatic C. difficile infection. Development of symptomatic C. difficile infection was compared among C. difficile carriers and noncarriers. Of the 220 subjects, 21 (9.6%) were C. difficile carriers, including 10.2% of the nursing facility residents and 7.7% of the community residents (P=0.60). This seems to be a higher colonization rate than in most previous studies. Among the 21 C. difficile carriers, 8 (38.1%) progressed to symptomatic C. difficile infection, but only 4 (2.0%) of the 199 noncarriers progressed to symptomatic C. difficile infection (hazard ratio, 23.9; 95% CI, 7.2-79.6; PC. difficile infection who progressed to symptomatic C. diff infection, the progression process was shorter than two weeks from enrollment in the study. Identifying asymptomatic carriers of C. difficile could help hospitals address the spread of C. difficile infections in two ways: first, isolation of C. difficile carriers could reduce transmission to uninfected patients, and second, interventions targeting C. difficile carriers could potentially prevent progression to symptomatic C. difficile Identifying asymptomatic carriers of C. difficile could help hospitals address the spread of C. difficile infections in two ways: First, isolation of C. difficile carriers could reduce transmission to uninfected patients, and second, interventions targeting C. difficile carriers could potentially prevent progression to symptomatic C. difficile. The question raised by this article is: should we be screening on admission and what preventive interventions can be used to prevent progression to active infection?
- 16 December 2019
- Published by H1 Connect
Faculty Opinions recommendation of Screening of Clostridioides difficile carriers in an urban academic medical center: Understanding implications of disease.
This is a prospective cohort single site study; the study included only 220 subjects, so it was small. Perirectal swabs were tested by PCR for C. difficile within 24 hours of admission, and patients were followed for progression to symptomatic C. difficile infection. Development of symptomatic C. difficile infection was compared among C. difficile carriers and noncarriers. Of the 220 subjects, 21 (9.6%) were C. difficile carriers, including 10.2% of the nursing facility residents and 7.7% of the community residents (P=0.60). This seems to be a higher colonization rate than in most previous studies. Among the 21 C. difficile carriers, 8 (38.1%) progressed to symptomatic C. difficile infection, but only 4 (2.0%) of the 199 noncarriers progressed to symptomatic C. difficile infection (hazard ratio, 23.9; 95% CI, 7.2-79.6; PC. difficile infection who progressed to symptomatic C. diff infection, the progression process was shorter than two weeks from enrollment in the study. Identifying asymptomatic carriers of C. difficile could help hospitals address the spread of C. difficile infections in two ways: first, isolation of C. difficile carriers could reduce transmission to uninfected patients, and second, interventions targeting C. difficile carriers could potentially prevent progression to symptomatic C. difficile Identifying asymptomatic carriers of C. difficile could help hospitals address the spread of C. difficile infections in two ways: First, isolation of C. difficile carriers could reduce transmission to uninfected patients, and second, interventions targeting C. difficile carriers could potentially prevent progression to symptomatic C. difficile. The question raised by this article is: should we be screening on admission and what preventive interventions can be used to prevent progression to active infection?
- 20 October 2019
- Published by H1 Connect
Faculty Opinions recommendation of Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America.
An important update from 2007 guidelines. This document provides guidance on diagnostic testing, updated antibiotic recommendations, added recommendation on procalcitonin, use of steroids, and elimination of the category healthcare-associated pneumonia (HCAP). The authors propose using local prevalence in patients with community-acquired pneumonia (CAP) in deciding whether methicillin-resistant Staphylococcus aureus (MRSA) or Pseudomonas aeruginosa is a potential pathogen.
- 20 October 2019
- Published by H1 Connect
Faculty Opinions recommendation of Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America.
An important update from 2007 guidelines. This document provides guidance on diagnostic testing, updated antibiotic recommendations, added recommendation on procalcitonin, use of steroids, and elimination of the category healthcare-associated pneumonia (HCAP). The authors propose using local prevalence in patients with community-acquired pneumonia (CAP) in deciding whether methicillin-resistant Staphylococcus aureus (MRSA) or Pseudomonas aeruginosa is a potential pathogen.
- 19 July 2019
- Published by H1 Connect
Faculty Opinions recommendation of Association Between Alcohol Use Disorders and Outcomes of Patients Hospitalized With Community-Acquired Pneumonia.
This is a retroactive study in patients admitted with community-acquired pneumonia (CAP) from the Premier Healthcare Database. The purpose of the review was to look at influence of alcohol use disorder (AUD) and outcomes. Patients with AUD were more likely to present with more severe illness and had a higher incidence of S. pneumoniae. However, AUD was associated with a lower incidence of antimicrobial resistance. After adjustment for comorbidities, AUD did not have higher mortality, but was associated with increased cost and longer hospitalization as well as mechanical ventilation. This article highlights that we often over estimate antimicrobial resistance, which drives unnecessary use of anti-staph and anti-pseudomonas agents, which impacts adverse drug events and increases pressure for antimicrobial resistance.
- 19 July 2019
- Published by H1 Connect
Faculty Opinions recommendation of Association Between Alcohol Use Disorders and Outcomes of Patients Hospitalized With Community-Acquired Pneumonia.
This is a retroactive study in patients admitted with community-acquired pneumonia (CAP) from the Premier Healthcare Database. The purpose of the review was to look at influence of alcohol use disorder (AUD) and outcomes. Patients with AUD were more likely to present with more severe illness and had a higher incidence of S. pneumoniae. However, AUD was associated with a lower incidence of antimicrobial resistance. After adjustment for comorbidities, AUD did not have higher mortality, but was associated with increased cost and longer hospitalization as well as mechanical ventilation. This article highlights that we often over estimate antimicrobial resistance, which drives unnecessary use of anti-staph and anti-pseudomonas agents, which impacts adverse drug events and increases pressure for antimicrobial resistance.